Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,253

Document Document Title
WO/2022/168989A1
Provided are a photochromic compound represented by general formula 1, a photochromic compound represented by general formula 2, and a photochromic compound represented by general formula 3. In general formula 1, R100 to R111, X1 and X2 ...  
WO/2022/167695A1
The present invention relates to chromen-4-one derivatives, and to associated multi-salts, solvates, and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatment and p...  
WO/2022/167697A1
The present invention relates to chromen-4-one derivatives, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatm...  
WO/2022/167696A1
The present invention relates to chromen-4-one derivatives, and to associated multi- salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treat...  
WO/2022/167700A1
The present invention relates to chromen-4-one derivatives, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatm...  
WO/2022/167699A1
The present invention relates to chromen-4-one derivatives, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatm...  
WO/2022/167867A1
The present disclosure relates in part to chemical modulators of protein phosphatase 2A (PP2A). The compounds of the present disclosure are useful in treating, preventing, and/or ameliorating cancer, diabetes, autoimmune disease, solid o...  
WO/2022/167698A1
The present invention relates to chromen-4-one derivatives, and to associated multi-salts, solvates, prodrugs and pharmaceutical compositions. The present invention also relates to the use of such compounds and compositions in the treatm...  
WO/2022/161895A1
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive chromophore, special polymerized compounds, and special monomer compounds being particularly suitable for compositions an...  
WO/2022/165165A1
Non-naturally occurring compositions comprising tetrahydrocannabinol (THC) and limonene and their use for treating THC-induced anxiety and/or paranoia are disclosed.  
WO/2022/162471A1
Disclosed are compounds, compositions, and methods useful for treating neuronal and mitochondrial diseases.  
WO/2022/165432A1
Disclosed herein are compounds that inhibit cullin-RING E3 ubiquitin ligase 4, a method of inhibiting the catalytic activity of a Cullin-RING E3 Ubiquitin (Ub) Ligase (CRL) in a cell, compositions comprising the inhibitor compounds, a me...  
WO/2022/162121A1
The present invention relates to butyrate compounds as well as to their synthesis and their use. Such compounds are very useful compounds, either as such or as intermediates in organic synthesis.  
WO/2022/160455A1
The present invention relates to the field of natural medicines, and particularly provides a compound for preventing and treating inflammation. The compound has a structure, as shown in formulas I-VIII, and belongs to a 2-(2-phenethyl) c...  
WO/2022/159504A1
This invention relates to deuterated tetrahydrocannabinol compounds, deuterated tetrahydrocannabivarin compounds, deuterated cannabigerol compounds, and deuterated cannabichromene compounds, methods for preparation thereof, compositions ...  
WO/2022/155741A1
The present disclosure describes cannabis products and methods for producing one or more activated cannabinoids, comprising decarboxylating one or more cannabinoid acids in a cannabis source; and grinding the cannabis source; to produce ...  
WO/2022/155757A1
The present disclosure relates to a cannabinoid emulsification system for making cannabis-infused products, particularly cannabis-infused products that include an aqueous component. The cannabinoid emulsification system comprises a canna...  
WO/2022/157338A1
Method for the production of cannabinoid acid esters of general formula (I) or (II) or (III) or (IV), wherein R1 consists of a straight or branched alkyl group, alkenyl group or alkynyl group having from 1 to 5 carbons, during the simult...  
WO/2022/156615A1
The present invention relates to a preparation method for a non-ester-type tea polyphenol rich in EGC, the method comprising: subjecting crushed and wall-broken tea leaves to enzymatic hydrolysis by using endogenous hydrolase at the cont...  
WO/2022/150435A1
This invention is directed to pharmaceutical compositions comprising tocotrienol and the use of such compositions to treat non-alcoholic steatohepatitis.  
WO/2022/149610A1
[Problem] To provide a guanidine derivative (in particular, an amino acid compound having a 4-guanidino group) which has a low production cost and is less likely to cause the problem of waste liquor, a method for producing the same and a...  
WO/2022/148752A2
The present disclosure relates to a photochromic molecule and uses of said molecule. The present disclosure further relates to a method of preparing a film comprising said molecule. The present disclosure also relates to a film prepared ...  
WO/2022/147872A1
The present invention relates to a series of amide derivative neutral mitochondrial fluorescent markers, a preparation method therefor, and an application thereof; the present invention discloses for the first time that, after being link...  
WO/2022/150681A1
The technology described herein is directed to methods and compositions for inhibtion of ClbP and the treatment and/or prevention of cancer, e.g., colorectal cancer, a urinary tract cancer, a squamous cell carcinoma, an oral squamous cel...  
WO/2022/140849A1
The present disclosure relates to cannabinoid compositions that have reduced bitter-tasting characteristics, which are suitable for making cannabis-infused products. The cannabinoid compositions effectively mask the bitter and off-taste ...  
WO/2022/146914A1
Described herein are compounds and methods of treating a disease or disorder, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effectiv...  
WO/2022/143715A1
An oxaspiro substituted pyrrolopyrazole derivative, an intermediate thereof, and a preparation method therefor.  
WO/2022/144436A1
The present invention refers to a process for the asymmetric synthesis of isopiperitenol and successor compounds.  
WO/2022/138967A1
The present invention provides a photochromic compound which is represented by general formula 1. In general formula 1, each of R30 and R31 independently represents a linear or branched alkyl group having two or more carbon atoms with or...  
WO/2022/138965A1
Provided is a photochromic composition comprising one or more types of compounds represented by general formula A and one or more types of compounds represented by general formula B. In general formula A, R1, R2, B1, and B2 each independ...  
WO/2022/135072A1
Provided in the present invention are a coumarin compound, a preparation method therefor, and the use and a pharmaceutical composition thereof, belonging to the technical field of medicines. The coumarin compound provided in the present ...  
WO/2022/138735A1
Although compounds for treating or ameliorating malignant diseases have been proposed, patients had to endure a large burden since many of such compounds could not be orally ingested. Mangiferin has an effect of ameliorating malignant di...  
WO/2022/138605A1
The present invention addresses the problem of providing a method for efficiently producing a peptide having a high purity, a reagent for forming a protective group having excellent deprotection properties, and a novel fused polycyclic c...  
WO/2022/138968A1
This photochromic composition contains a predetermined combination of: at least one photochromic compound represented by general formula 1; and at least one selected from the group consisting of a photochromic compound represented by gen...  
WO/2022/138909A1
[Problem] The present invention provides: an equol clathrate having improved solubility in water; an equol-absorbent composition containing the equol clathrate; a production method for the clathrate; and an equol-absorbent composition co...  
WO/2022/138966A1
Provided is a photochromic composition containing one or more types of compounds represented by general formula A, one or more types of compounds represented by general formula B, and one or more types of compounds represented by general...  
WO/2022/133027A1
Compounds of formula (1) wherein R1 represents a -C(R2)(R3)-[C(R4)(R5)]m-L-R6 group or -R7; and the preparation and the therapeutic uses of the compounds of formula (1) as agonists of TRPM8 receptors, useful especially in the treatment o...  
WO/2022/133362A1
Disclosed are facile methods of purifying a cannabis extract to produce highly purified, crystallized cannabinoid acids, and in particular cannabinoid acids such as THCA, and removing impurities from the same, by using polar aprotic solv...  
WO/2022/128832A1
The present invention relates to novel ophthalmic devices comprising polymerized compounds comprising a photoactive chromophore, said polymerized compounds, and special monomer compounds being particularly suitable for compositions and o...  
WO/2022/125966A1
A method of removing THC and/or THCA from a mixture, the mixture including THC and/or THCA and at least one cannabinoid is provided. The method comprises passing a first feedstock stream through a first chromatographic resin arranged in ...  
WO/2022/124994A1
Provided is a method for coupling flavonoid-containing compounds to provide flavonoid dimers, trimers and oligomers. The method comprises contacting a flavonoid-containing compound with base in the presence of air. Flavonoid dimers, trim...  
WO/2022/122975A1
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, for use as a drug, especially as an antibiotic. The present invention also relates to a pharmaceutical composition c...  
WO/2022/115971A1
Disclosed are methods for separating, recovering, and purifying CBGA, CBDVA, THCVA, CBCVA, and CBCA from dewatered and desolventized crude complex extracts or mixtures of metabolites, cannabinoids, and cannabis phytochemicals. The method...  
WO/2022/115953A1
The present disclosure describes compositions including a eutectic matrix that includes methylsulfonylmethane and a sugar alcohol and particles of a nutraceutical in the eutectic matrix. In some embodiments, the sugar alcohol:methylsulfo...  
WO/2022/120048A1
The present disclosure is directed to chromane compounds, chromane compounds demonstrating HDAC inhibition, and pharmaceutical compositions thereof. Additional embodiments include methods of using the chromane compounds. For example, the...  
WO/2022/118303A1
The present disclosure relates to methods of treating cancer and, more particularly, an active agent selected from the group consisting of tetrahydrocannabinol (THC), cannabidiol (CBD), or combinations thereof, in a dosage form for trans...  
WO/2022/118186A1
It is provided a senotherapeutic compound comprising a synthetic derivative of flavones, according to the formula (I), in which at least two of R2-R6 are H, and the remainder are individually selected from: H, OH, R1, OR1, NO2, NH2, NHR1...  
WO/2022/115973A1
Disclosed are methods for precipitation of CBDA-amine salts and THCA-amine salts from concentrated crude complex extracts. The crude complex extracts may be recovered from cannabis biomass or fermentation systems wherein microorganisms w...  
WO/2022/109736A1
Described herein is a polypeptide encoding a prenyltransferase for prenylating a polyphenol and a polypeptide encoding an O-methyltransferase for methylating a polyphenol. For example, the polypeptide comprises or consists of the sequenc...  
WO/2022/113047A1
This invention relates to compounds that are 4'-substituted analogues of the flavonol Fisetin. In particular, the invention relates to such compounds wherein the 4' position on the B-ring is substituted with a ring deactivating group whi...  

Matches 1 - 50 out of 11,253